Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
04 Marzo 2019 - 11:30PM
Edgar (US Regulatory)
Filed by Edge Therapeutics, Inc.
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed under Rule 14a-6(b) of the Securities Exchange Act of 1934
Subject Company: Edge Therapeutics, Inc.
Commission File No. 001-37568
Grafico Azioni EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni EDGE THERAPEUTICS, INC. (NASDAQ:EDGE)
Storico
Da Mag 2023 a Mag 2024
Notizie in Tempo Reale relative a Edge Therapeutics, Inc. (NASDAQ): 0 articoli recenti
Più Edge Therapeutics, Inc. Articoli Notizie